Nirsevimab Greatly Reduced Severe RSV in Infants
For infants in their first RSV season, the monoclonal antibody Nirsevimab (Beyfortus) was 80% effective against RSV-related ICU admission and...
For infants in their first RSV season, the monoclonal antibody Nirsevimab (Beyfortus) was 80% effective against RSV-related ICU admission and...
The primary aim of this study was to determine whether oral glycine supplementation would correct its deficiency in individuals with...
Key TakeawaysPeople with severe obesity are more likely to face discrimination when seeking medical careAbout 2 out of 5 clinics...
Levent Konuk / iStock Enterovirus D68 (EV-D68) can cause severe acute respiratory illness (ARI) in otherwise healthy children of all...
As the winds pick up, they soon become powerful gusts, causing the Franklin Mountains to vanish into a swirling haze...
News ReleaseTuesday, September 10, 2024A scientific team supported by the National Institutes of Health (NIH) has created a preclinical blood...